Langer said joining ACT at this pivotal juncture in stem cell therapy history “appeals to the scientist in me.” He added, “ACT is poised to make a substantial contribution to the progression of regenerative medicine, with a potential to have a significant impact on the treatment of diseases, especially ones for which current medicines and treatments are not adequate.”